S. Hutchinson

Patient-derived tumor xenograft and organoid models established from resected pancreatic, duodenal and biliary cancers

L. Muthuswamy, M. Tsao, S. Gallinger, 2021, Scientific Reports.

Molecular characterisation of pancreatic ductal adenocarcinoma with NTRK fusions and review of the literature

F. Notta, S. Gallinger, R. Denroche, 2021, Journal of Clinical Pathology.

GATA6 Expression Distinguishes Classical and Basal-like Subtypes in Advanced Pancreatic Cancer

R. Khokha, F. Notta, J. Bartlett, 2020, Clinical Cancer Research.

Impact of KRAS mutational status on outcomes in patients with pancreatic cancer (PDAC).

F. Notta, S. Gallinger, R. Denroche, 2021 .

Can preoperative liver MRI with gadoxetic acid help reduce open-close laparotomies for curative intent pancreatic cancer surgery?

C. Moulton, K. Jhaveri, S. Gallinger, 2021, Cancer Imaging.

A Risk Score Model for Locoregional Recurrence Following Upfront Surgery for Pancreatic Adenocarcinoma: Implications for Adjuvant Therapy.

C. Moulton, L. Dawson, J. Brierley, 2021, Clinical oncology (Royal College of Radiologists (Great Britain)).

Systemic inflammatory prognostic scores in advanced pancreatic adenocarcinoma

R. Khokha, F. Notta, S. Gallinger, 2023, British Journal of Cancer.

Homologous recombination deficiency (HRD) scoring in pancreatic ductal adenocarcinoma (PDAC) and response to chemotherapy.

F. Notta, S. Gallinger, R. Denroche, 2020 .

Outcomes and Immunogenicity of pancreatic cancer stratified by the HRDetect score.

F. Notta, S. Gallinger, R. Denroche, 2020 .

hENT1 expression predicts response to gemcitabine and nab-paclitaxel in advanced pancreatic ductal adenocarcinoma (PDAC).

F. Notta, S. Gallinger, R. Denroche, 2022, Clinical cancer research : an official journal of the American Association for Cancer Research.

Impact of an Inter-Professional Clinic on Pancreatic Cancer Outcomes: A Retrospective Cohort Study

C. Moulton, N. Dhani, A. Dodd, 2024, Current Oncology.